VICTORY CAPITAL MANAGEMENT INC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 205 filers reported holding BRIDGEBIO PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.8%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$11,481,841
+20.6%
435,413
-21.4%
0.01%
+30.0%
Q2 2023$9,524,208
+4669.9%
553,733
+4498.0%
0.01%
Q1 2023$199,673
-69.3%
12,043
-85.9%
0.00%
-100.0%
Q4 2022$649,956
-57.0%
85,296
-43.9%
0.00%
-50.0%
Q3 2022$1,510,000
+64.1%
151,921
+49.9%
0.00%
+100.0%
Q2 2022$920,000
-7.0%
101,365
+0.9%
0.00%0.0%
Q1 2022$989,000
-41.9%
100,416
-1.6%
0.00%
-50.0%
Q4 2021$1,702,000
+229.8%
102,019
+826.7%
0.00%
+100.0%
Q3 2021$516,000
-25.0%
11,009
-2.5%
0.00%0.0%
Q2 2021$688,000
-11.2%
11,292
-10.3%
0.00%0.0%
Q1 2021$775,000
-3.5%
12,583
+11.4%
0.00%0.0%
Q4 2020$803,000
+103.8%
11,293
+7.5%
0.00%0.0%
Q3 2020$394,000
-84.9%
10,504
-86.9%
0.00%
-75.0%
Q2 2020$2,607,000
-48.3%
79,960
-54.0%
0.00%0.0%
Q1 2020$5,046,000
+59.4%
173,972
+92.7%
0.00%0.0%
Q4 2019$3,165,000
-81.6%
90,290
-88.7%
0.00%
-81.8%
Q3 2019$17,219,000
+1.1%
801,989
+26.9%
0.02%
-35.3%
Q2 2019$17,039,000631,7890.03%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders